Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors | Zendy

Omid Fotouhi | Zendy; Hanna Kjellin | Zendy; Catharina Larsson | Zendy; Jamileh Hashemi | Zendy; Jorge Barriuso | Zendy; C. Christofer Juhlin | Zendy; Ming Lu | Zendy; Anders Höög | Zendy; Laura Guerra | Zendy; Ángela Lamarca | Zendy; Victoria Heredia-Soto | Zendy; Jan Zedenius | Zendy; Marta Mendiola | Zendy; Janne Lehtiö | Zendy; Magnus Kjellman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors

Author(s) -

Omid Fotouhi,

Hanna Kjellin,

Catharina Larsson,

Jamileh Hashemi,

Jorge Barriuso,

C. Christofer Juhlin,

Ming Lu,

Anders Höög,

Laura Guerra,

Ángela Lamarca,

Victoria Heredia-Soto,

Jan Zedenius,

Marta Mendiola,

Janne Lehtiö,

Magnus Kjellman

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-2028

Subject(s) - survivin , lanreotide , somatostatin , cancer research , neuroendocrine tumors , medicine , endocrinology , somatostatin receptor , biology , cancer , acromegaly , hormone , growth hormone

Somatostatin analogs are established in the treatment of neuroendocrine tumors (NETs) including small intestinal NET; however, the molecular mechanisms are not well known. Here, we examined the direct effects of lanreotide in NET cell line models.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research